Verona Pharma plc (VRNA) reported Loss for its fourth quarter of -$33.827 million
The company's earnings totaled -$33.827 million, or -$0.05 per share. This compares with -$14.132 million, or -$0.02 per share, last year.
Verona Pharma plc earnings at a glance (GAAP) :
-Earnings: -$33.827 Mln. vs. -$14.132 Mln. last year.-EPS: -$0.05 vs. -$0.02 last year.-Revenue: $36.655 Mln vs. $00.000 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.